| Immunologic alterations and active aspecific immunotherapy in lung cancer patients. | |
| | |
MedLine Citation:
|
PMID: 6195126 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
An immunologic study was undertaken on 89 lung cancer patients and on the basis of results obtained so far, a protocol of active, aspecific immunotherapy by living bacterial vaccines (BCG) and/or synthetic immunopotentiator (methisoprinol) was carried out. First results obtained in patients undergoing immunostimulation are reported together with the observation that while positive humoral effects seem present in stage I and II patients, in cases of spread of the disease results are substantially negative. |
| | |
Authors:
|
P Banna; R Murabito; A Saggio; F Cordopatri; M Riggi; M E Campo; C Cinà; S Latteri |
Related Documents
:
|
18932026 - Characteristics of lung cancer patients with asbestos-related radiological findings. 16685016 - The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleur... 18668536 - Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient wi... 8180446 - Clinical characteristics of idiopathic interstitial pneumonia (iip) with bullae. 21193056 - Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after al... 598056 - Folic acid status of patients with chronic renal failure maintained by dialysis. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Italian journal of surgical sciences / sponsored by Società italiana di chirurgia Volume: 13 ISSN: 0392-3525 ISO Abbreviation: Ital J Surg Sci Publication Date: 1983 |
Date Detail:
|
Created Date: 1983-12-20 Completed Date: 1983-12-20 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8213451 Medline TA: Ital J Surg Sci Country: ITALY |
Other Details:
|
Languages: eng Pagination: 133-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenocarcinoma
/
therapy* Adult BCG Vaccine / therapeutic use* Carcinoma, Small Cell / therapy* Carcinoma, Squamous Cell / therapy* Humans Immunoglobulins / analysis Immunotherapy Inosine / analogs & derivatives* Inosine Pranobex / therapeutic use* Lung Neoplasms / therapy* Lymphocyte Activation Male Middle Aged Rosette Formation |
| Chemical | |
Reg. No./Substance:
|
0/BCG Vaccine; 0/Immunoglobulins; 36703-88-5/Inosine Pranobex; 58-63-9/Inosine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Spectrographic determination of zinc in the tissues of adenoma and carcinoma of the prostate.
Next Document: An animal model for the assessment of microvascular patency.